Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02026271
Title A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ziopharm
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cedars-Sinai Los Angeles California 90048 United States Details
University of California - San Francisco San Francisco California 94143 United States Details
Northwestern Chicago Illinois 60611 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Brigham & Women's Boston Massachusetts 02115 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field